Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Hermiston › NPI 1295789667
Clinic

Good Shepherd Health Care System

Good Shepherd Health Care System was paid $30.70M by Medicaid between Jan 2018 and Dec 2024, across 153 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.

33Billing provider infoGOOD SHEPHERD HEALTH CARE SYSTEM
HERMISTON, OR 97838
33aNPI1295789667assigned 05/20/2006
33bProvider typeUrgent Care Clinic/Center
28Total paid$30.70M
24GClaims469,852
24DCodes billed153
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Urgent Care Clinic/Center providers in Oregon

Rank by total paid#1 of 20
Median peer was paid$636K
This provider vs. median48×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201854,021$3.17M
201953,506$3.42M
202054,513$3.13M
202172,345$4.25M
202283,387$5.11M
202380,673$5.26M
2024incomplete71,407$6.36M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 31% 45,630 29,963 $9.61M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 30% 66,831 44,798 $9.10M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.6% 6,150 3,563 $2.03M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.3% 24,740 19,143 $1.94M
71045 Radiologic examination, chest; single view 3.0% 19,095 7,709 $908K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.1% 12,188 9,692 $634K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 1,116 506 $588K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.5% 8,553 3,946 $457K
96375 Therapeutic injection; each additional sequential IV push 1.5% 7,980 6,683 $451K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.4% 8,197 3,605 $432K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.4% 11,942 10,199 $429K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.4% 4,218 3,768 $421K
141 more codes
96361 Intravenous infusion, hydration; each additional hour 1.3% 8,210 $384K
99215 Doctor's office visit, returning patient (complex) 1.2% 2,082 $355K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,083 $265K
70450 Computed tomography, head or brain; without contrast material <1% 1,264 $227K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 12,481 $194K
80053 Comprehensive metabolic panel <1% 31,956 $182K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 1,346 $162K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,541 $160K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 37,497 $158K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 9,365 $132K
36415 Collection of venous blood by venipuncture <1% 50,301 $119K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,306 $113K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 1,496 $101K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 284 $93K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,578 $88K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,080 $85K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,382 $69K
J2704 Injection, propofol, 10 mg <1% 2,326 $52K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 187 $51K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,207 $49K
81000 <1% 17,130 $39K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,578 $37K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 1,980 $35K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,546 $34K
84484 <1% 5,801 $33K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,220 $29K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 367 $29K
73630 <1% 280 $25K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 613 $22K
83690 <1% 5,097 $21K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 305 $18K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,333 $17K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 20 $17K
84703 <1% 2,932 $16K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,242 $16K
84443 Thyroid stimulating hormone (TSH) <1% 2,036 $15K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 502 $14K
83036 Hemoglobin; glycosylated (A1C) <1% 3,063 $13K
83880 <1% 835 $13K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 360 $11K
76830 Ultrasound, transvaginal <1% 64 $10K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,205 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,475 $9K
95806 <1% 77 $9K
99203 Doctor's office visit, new patient (routine) <1% 226 $9K
80048 Basic metabolic panel (calcium, ionized) <1% 2,298 $8K
C9290 Injection, bupivacaine liposome, 1 mg <1% 44 $8K
80061 Lipid panel <1% 1,551 $8K
76819 Fetal biophysical profile; without non-stress testing <1% 44 $7K
96376 <1% 247 $7K
85610 <1% 3,655 $5K
81025 <1% 966 $5K
98942 <1% 751 $5K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 131 $5K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 28 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 294 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 222 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 292 $4K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits <1% 181 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 245 $4K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 55 $4K
29581 <1% 67 $4K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 134 $3K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 172 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 608 $3K
83605 <1% 565 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 74 $3K
99239 Hospital discharge day management, more than 30 minutes <1% 37 $3K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 102 $3K
86780 <1% 324 $2K
84439 <1% 505 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 82 $2K
82803 <1% 107 $2K
85730 <1% 634 $2K
73610 <1% 32 $2K
86850 <1% 182 $2K
71046 Radiologic examination, chest; 2 views <1% 24 $2K
83735 <1% 492 $2K
82043 <1% 907 $2K
86803 <1% 180 $2K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 28 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 359 $2K
J3490 Unclassified drugs <1% 64 $1K
87653 <1% 70 $1K
84481 <1% 162 $1K
J7120 Ringers lactate infusion, up to 1000 cc <1% 57 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 88 $1K
73562 <1% 21 $1K
83970 <1% 96 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 33 $1K
84702 <1% 79 $973.17
87481 <1% 132 $900.54
85027 <1% 342 $876.36
87660 <1% 64 $873.60
87480 <1% 65 $873.60
87510 <1% 65 $873.60
86762 <1% 86 $785.46
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 29 $758.25
87486 <1% 29 $758.25
87581 <1% 29 $758.25
80069 <1% 277 $707.02
85379 <1% 95 $622.44
87077 <1% 184 $609.21
87340 <1% 86 $556.71
87186 <1% 140 $504.90
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 33 $500.65
84550 <1% 303 $473.91
99441 <1% 37 $424.16
82607 <1% 46 $380.16
87040 <1% 50 $357.55
82962 <1% 207 $336.86
82550 <1% 82 $336.29
82150 <1% 78 $309.49
99232 Hospital visit by a doctor, follow-up day <1% 24 $298.87
82947 <1% 124 $283.95
82330 <1% 33 $279.96
86140 <1% 86 $270.74
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 116 $243.69
85652 <1% 79 $185.11
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 33 $179.69
83874 <1% 15 $168.59
84156 <1% 119 $159.34
84100 <1% 16 $155.51
84132 <1% 48 $148.60
84295 <1% 49 $148.32
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 66 $128.59
82565 <1% 34 $127.92
82435 <1% 49 $124.13
83655 <1% 14 $118.72
82746 <1% 17 $113.19
86900 <1% 54 $105.72
86901 <1% 54 $105.72
83516 <1% 24 $102.67
86141 <1% 12 $99.77
82784 <1% 12 $82.84
J2060 Injection, lorazepam, 2 mg <1% 32 $76.15
87015 <1% 14 $51.48
85014 <1% 33 $50.24
98943 <1% 21 $26.01
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 15 $20.37
81003 <1% 12 $12.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEDWARDS, JONATHAN (COO & CFO)
Same official

Other billing entities under EDWARDS, JONATHAN

Full network →
ProviderLocationPaid
Good Shepherd Health Care SystemHermiston, OR$877K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.